Likely to seek FIPB approval to raise holding; deal could bring FDI of about $696 mn.
Under the banner of the CII, domestic drug majors have approached Cabinet Secretary BK Chaturvedi for being allowed to present their views on the new pharmaceutical policy, scheduled to be discussed by the Union Cabinet on Thursday.
With the Jaypee acquisition, the Suraksha group, which made lenders an offer of Rs 7,736 crore, will be able to expand its footprint in north India after making inroads in Mumbai's real estate market over the past year. Sudhir Valia, the promoter, was a co-founder and executive director of India's biggest pharmaceutical firm, Sun Pharmaceuticals, and is a close relative of Dilip Shanghvi.
The list, comprising 48 people, also includes four each from Australia, China, Hong Kong, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan and Thailand.
HR Guru Mayank Rautela offers practical advice.
The serial blasts are unlikely to completely derail commercial activity in Mumbai.
One smells a rat when cases are settled for too small a price offered either by the highest bidder or the promoter -- within and outside the legal ambit of insolvency process, observes Tamal Bandyopadhyay.
Piramyd Retail shares opened at the Bombay Stock Exchange on Monday at Rs 146 against an issue price of Rs 120.
Akash Ambani and Shloka Mehta get ready for the next big wedding in town.
Mayank Rautela distils his 20-odd years of experience in human resources management to tell you how you can ace in your career.
Company aims to build five Rs 100 cr-plus brands and launch products from South African arm in domestic market
Leaders need to be ready to adapt to technological changes as quickly as possible, while they build the tech capabilities, Nadella said.
Food regulator has closed more than 15 files.
B-Town was in full attendance at the wedding.
The mid-cap universe - comprising firms that rank 101-250 in terms of m-cap - could see as many as 17 new stocks move out. Similarly, over half a dozen stocks could exit the large-cap universe, which is defined as the top 100 entities in terms of m-cap.
With local companies facing stress in domestic operations, valuations are down.
All of these companies are present in India.
HR Guru Mayank Rautela offers practical advice.
HR Guru Mayank Rautela offers practical advice.
Not far back, in 2010, SRL Diagnostics, promoted by former Ranbaxy promoters Malvinder and Shivinder Singh, acquired the diagnostic services business of Piramal Healthcare for Rs 600 crore (Rs 6 billion).
Prime property rates in South Mumbai at Rs 60,000 a sq ft remain high despite a slowing realty market.
Indian auto and pharma industries import several critical components and raw materials from China.
The company will spend Rs 10,141 crore to buy 15.5 per cent stake from minority investors.
The Delhi High Court on Friday stayed the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.
Isha is set to tie the knot with Anand Piramal this week.
CPPIB is looking to partner with RMZ because the latter is aggressive on both new developments and acquisitions.
It takes 6 to 8 months after the approval for a product to hit stores.
A Piramal social venture enables people all over Rajasthan to call 104 toll free to seek medical advice.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances